More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

A dose of the new Moderna spikevax autumn Covid booster vaccination before it is ... More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured ...

Moderna's new version of its COVID-19 vaccine, which targets two virus variants ... and is being positioned as a second booster shot that could be used in forthcoming immunisation campaigns.

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...

Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...

Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

High vaccine wastage and low vaccination and booster rates marred the government’s P74.68-million COVID-19 National ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

Kennedy Jr. Wednesday during a Senate Finance hearing about his decision to keep a financial stake in litigation against a major vaccine maker. Ethics records released in advance of the hearing ...